Novel Approaches Identifying Relevant Patient-Reported Outcomes in Patients With Inflammatory Bowel Diseases-LISTEN

被引:5
|
作者
Teich, Niels [1 ,2 ]
Schulze, Hermann [3 ]
Knop, Jana [4 ]
Obermeier, Michael [5 ]
Stallmach, Andreas [6 ]
机构
[1] Internist Gemeinschaftspraxis Verdauungs & Stoffw, Leipzig, Germany
[2] Friedrich Schiller Univ Jena, Med Fac, Jena, Germany
[3] AGAPLESION Med Care Ctr, Frankfurt, Germany
[4] Takeda Pharma Vertrieb GmbH & Co KG, Jagerstr 27, D-10117 Berlin, Germany
[5] GKM Gesell Therapieforsch GmbH, Munich, Germany
[6] Jena Univ Hosp, Dept Internal Med 4, Jena, Germany
关键词
Crohn's disease; ulcerative colitis; patient relevance; self-reported experience; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; OLMSTED COUNTY; PREVALENCE; CROHNS; MINNESOTA; DIAGNOSIS; IMPACT;
D O I
10.1093/crocol/otab050
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Several patient-reported outcomes (PROs) have been established and are widely used in the assessment of patients with inflammatory bowel disease (IBD). However, it has never been investigated which PRO items are experienced by and are considered most relevant for IBD patients. Methods: A review of IBD-related disease scores by a steering committee led to the identification of relevant PRO questions and assignment to 16 different PRO categories (9 symptoms and 7 impacts) that characterize patient's disease burden. In a cross-sectional study, a digital patient survey was carried out to determine the self-reported experience by multiple response, the relevance of these PRO categories by pairwise comparison and the suitability of the respective questions and answer possibilities by yes-or-no-question. Results: Sixty patients with Crohn's disease (CD) (56.7% women; mean age 40.6 years; mean disease duration 12.4 years) and 60 patients with ulcerative colitis (UC) (51.7% women; mean age 37.3 years; mean disease duration 9.0 years) participated in the patient survey. All predefined symptoms and impacts, with the exception of nausea, were experienced by at least 50% of patients. Stool urgency and pain were rated the 2 most important symptoms in CD patients with similar ratings for relevance. Stool urgency was also the most important symptom in patients with UC, followed by stool frequency. Differences in self-reported experience between CD and UC patients were seen for the symptoms of rectal bleeding, pain, and nausea. Most important impact of symptoms in both patient groups were general wellbeing followed by social activities, while sexual activity was the least relevant impact category. Conclusions: Stool urgency was the most relevant and most self-reported symptom for both CD and UC. Relevance and self-reported experience of pain and rectal bleeding differed between the 2 diseases. Therefore, the future collection of PROs should take these disease specificities into consideration. Lay Summary This study showed that stool urgency, stool frequency, and either pain for Crohn's disease patients or rectal bleeding for patients with ulcerative colitis were considered the most relevant symptoms. Thus, emphasis on patient reporting outcomes with focus on these categories is advised.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Patient-reported outcomes in daily clinical care of patients with inflammatory bowel diseases
    Hoefkens, E.
    Pouillon, L.
    Buydens, Y.
    Bossuyt, P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S559 - S559
  • [2] Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases
    Nghia H. Nguyen
    Xian Zhang
    Millie D. Long
    William J. Sandborn
    Michael D. Kappelman
    Siddharth Singh
    Digestive Diseases and Sciences, 2022, 67 : 2039 - 2048
  • [3] Patient-Reported Outcomes and Risk of Hospitalization and Readmission in Patients with Inflammatory Bowel Diseases
    Nguyen, Nghia H.
    Zhang, Xian
    Long, Millie D.
    Sandborn, William J.
    Kappelman, Michael D.
    Singh, Siddharth
    DIGESTIVE DISEASES AND SCIENCES, 2022, 67 (06) : 2039 - 2048
  • [4] Changes in Patient-Reported Outcomes With Vedolizumab Therapy in Patients With Inflammatory Bowel Diseases (IBD)
    Long, Millie D.
    Martin, Christopher
    Chen, Wenli
    Jaeger, Elizabeth
    Barocas, Morris
    Luo, Michelle
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S342 - S342
  • [5] Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle
    Restellini, S.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1085 - 1086
  • [6] Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases
    Bossuyt, Peter
    Hoefkens, Eveline
    Pouillon, Lieven
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1839 - 1839
  • [7] Patient-reported healthcare expectations in inflammatory bowel diseases
    Pittet, Valerie
    Vaucher, Carla
    Froehlich, Florian
    Maillard, Michel H.
    Michetti, Pierre
    PLOS ONE, 2018, 13 (05):
  • [8] Prime Time Was Yesterday for Patient-reported Outcomes in Daily Care of Patients With Inflammatory Bowel Diseases Reply
    Melmed, Gil Y.
    Cohen, Erica R.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (11) : 1840 - 1840
  • [9] Evaluation of the Patient-Reported Outcomes Measurement Information System in a Large Cohort of Patients With Inflammatory Bowel Diseases
    Kappelman, Michael D.
    Long, Millie D.
    Martin, Christopher
    DeWalt, Darren A.
    Kinneer, Patricia M.
    Chen, Wenli
    Lewis, James D.
    Sandler, Robert S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) : 1315 - +
  • [10] Patient-reported Outcomes in a French Nationwide Survey of Inflammatory Bowel Disease Patients
    Williet, Nicolas
    Sarter, Helene
    Gower-Rousseau, Corinne
    Adrianjafy, Charlotte
    Olympie, Alain
    Buisson, Anne
    Beaugerie, Laurent
    Peyrin-Biroulet, Laurent
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (02): : 165 - 174